SEI Investments’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
SEI Investments's TSHA Position: Q3 2026 in Review
SEI Investments increased its Taysha Gene Therapies (TSHA) stake by 1,062% in Q3 2026, buying an estimated $854K and bringing the position to 162,062 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.
SEI Investments first reported a position in TSHA in Q3 2024 and has held it in 5 quarters since. 205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.
- SEI Investments held 162,062 shares of Taysha Gene Therapies worth $789K as of Q3 2026.
- SEI Investments bought 148,110 Taysha Gene Therapies shares in Q3 2026, an estimated $854K.
- Taysha Gene Therapies made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2420 holding.
- SEI Investments first reported a position in Taysha Gene Therapies in Q3 2024 and has held it in 5 quarters since.
- 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.